Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS - Wikidata - wikimedia - TriplyDB

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

http://www.wikidata.org/entity/Q35220408

about

New molecular insights into peripheral T cell lymphomas miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.STAT3 signaling induces the differentiation of human ICOS(+) CD4 T cells helping B lymphocytes.S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.Genetics of anaplastic large cell lymphoma The role of B7 family molecules in hematologic malignancy The B7 homologues and their receptors in hematologic malignancies.The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis: alternative drivers in anaplastic large cell lymphoma.Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.A three-signal model of T-cell lymphoma pathogenesis Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.

P2860

Q27026081-AA9340E4-F84C-4B49-B055-BB804D2E2CCE Q30419258-D1EADD1C-6E06-4E96-82BD-A3D5CFBD4CD0 Q34907773-C4EA7B4C-5337-4070-A8B3-9ADD08393148 Q36177932-187F6785-F050-4DC0-8FEA-79BF68219473 Q36519797-92C696D8-EEA5-40AB-8AC0-EDFC04C73EA9 Q36584814-6ABFFA3B-60E4-44CE-8240-A1519948AF8E Q37988965-2302B173-3D4B-4F63-A29F-F2519E7802ED Q38101044-CA054A32-BE86-41FB-A641-BB44651B95E2 Q38106810-F2B710DD-7AB2-4727-BEFE-0A724BC1CA99 Q38190915-CFC74EBA-08ED-4F4A-A595-2B4D16D09A1E Q38593164-1800E645-2751-4A6B-9FC3-0A3C4A429ADE Q38644718-3E59C409-7EC4-4E37-B9FC-BD4B3EFF6BF7 Q38714687-0D855D44-4248-4D32-8F4E-ABDEABD44F62 Q42254184-3C532E7A-2CA5-4CA3-8CDB-61371ECCC30D

P2860

Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS

http://www.wikidata.org/entity/Q35220408

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@ast

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@en

type

label

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@ast

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@en

prefLabel

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@ast

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@en

P1433

Q35220408-75B12506-DAC4-45B9-B71C-797C940A6036

P1476

Q35220408-4935F9F0-0EB9-4278-B074-BD5C4766877B

P2093

Q35220408-08C4F856-27E5-4256-AF5D-C5882B15DE1A

Q35220408-142D0B02-C9B8-4CE7-8EDE-45645E3E09C5

Q35220408-404DFEB2-B052-4C86-BB13-32B091EE934B

Q35220408-58C78AD6-ADF4-4C9E-93EB-9FF916F2A7D2

Q35220408-5D81EC07-824F-45FC-9166-E5516911051F

Q35220408-68669DBB-FB36-42F3-9FD6-F0C621D1744E

Q35220408-820E57B5-EA03-492E-A650-58586639A293

Q35220408-A9EF1641-A76D-42E4-8142-D594CB841894

Q35220408-B9552438-2F95-4C2D-8274-0870E6FBB91F

Q35220408-F8AAAF56-3B05-4FBD-93C2-DE9756965C29

P2860

Q35220408-0762F4C8-EF93-4835-BF05-9DE78E518840

Q35220408-280CBAD4-2131-44BE-917B-DA7BA0C43801

Q35220408-2E0D4392-467C-4597-825E-882375B2C962

Q35220408-43AF79DD-96D4-4CD6-A680-C9EFF7D9C2D4

Q35220408-614A612B-7CF3-425F-9015-6E825627EDF5

Q35220408-6285D3E0-4282-4CBD-BB11-A2114395811B

Q35220408-63CFB2FE-C406-4BE2-BE42-430CCC726256

Q35220408-66F273D4-2A57-4600-9CAB-EDD0FF340FE0

Q35220408-66F91A90-FD6B-47DE-AD23-97C40129A10F

Q35220408-6B141E92-8A80-4501-A30E-F83A26BC2CC7

P304

Q35220408-4A431F42-F2E1-44EA-87DE-33FCD7F86F04

P31

Q35220408-EE4EFFB3-56E2-47CB-A5EF-857C881F8890

P356

Q35220408-E9A2470C-5AAA-497A-8D20-D4583E957667

P407

Q35220408-2B01EB6E-EF28-4369-B763-410E3443B84B

P433

Q35220408-27F89B8A-7115-41DE-A14C-8C1846E656F8

P478

Q35220408-2C6867A3-90AF-4A84-8D53-111DB68EFE72

P50

Q35220408-85E67555-333F-478E-84ED-0106A59E6572

P577

Q35220408-859DD63B-022E-479D-830B-32355F0801D7

P5875

Q35220408-C877AC12-8E4B-4972-89F1-05F29522E1BC

P698

Q35220408-1E517055-1831-4264-AA68-EF67BB0C1325

P932

Q35220408-B0E07DAA-8C41-42BB-A306-C4FAA104820E

P356

BLOOD-2011-01-332916

P1433

P1476

Oncogenic tyrosine kinase NPM- ...... growth-promoting receptor ICOS

@en

P2093

Andras Schaffer

http://www.w3.org/2001/XMLSchema#string

Chrystal Paulos

http://www.w3.org/2001/XMLSchema#string

Hongyi Wang

http://www.w3.org/2001/XMLSchema#string

Jennifer C Paterson

http://www.w3.org/2001/XMLSchema#string

Kanchan Kantekure

http://www.w3.org/2001/XMLSchema#string

Mariusz A Wasik

http://www.w3.org/2001/XMLSchema#string

Michael C Milone

http://www.w3.org/2001/XMLSchema#string

Niels Odum

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

Teresa Marafioti

http://www.w3.org/2001/XMLSchema#string

P2860

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation

Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

The epigenomics of cancer

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy.

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.

Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses

Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis.

P304

3062-3071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2011-01-332916

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Suzanne D Turner

P577

2011-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51498299

http://www.w3.org/2001/XMLSchema#string

P698

21765024

http://www.w3.org/2001/XMLSchema#string

P932

3175783

http://www.w3.org/2001/XMLSchema#string